http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_76c29db2f36bcd9ec40d1cb9f5c53782
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Manoukian |
| name | Siranoush Manoukian |
| given-name | Siranoush |
| organization-name | Unit of Medical Genetics, Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori (INT) Milan Italy Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan - Italy Unit of Genetics, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy 7Department of Experimental Oncology, Istituto Nazionale Tumori; Unit of Medical Genetics, Department of Medical Oncology and HematologyFondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan Italy Department of Preventive and Predictive Medicine, Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, Unit of Medical Genetics, Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy Unit of Medical Genetics, Department of Medical Oncology and Hematology Fondazione IRCCS Istituto Nazionale dei Tumori di Milano Milan Italy From the Department of Oncology and Surgical Sciences, Oncology Section; Istituto Oncologico Veneto - IRCCS, Padua; U.O.A. ULSS 5 Ovest Vicentino, Vinicenza; Fondazione IRCCS Istituto Nazionale Tumori; FIRC Institute of Molecular Oncology Foundation; and the European Institute of Oncology, Milan, Italy 9Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy Unit of Medical Genetics, Department of Medical Oncology and Hematology; Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Instituto Nazionale Tumori (INT); Milan Italy 19Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), Istituto Nazionale dei Tumori di Milano, Milan, Italy. 2Department of Experimental Oncology, Istituto Nazionale Tumori, Milan, Italy Unit of Medical Genetics; Department of Medical Oncology and Hematology; Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT); Milan Italy Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Unit of Medical Genetics Department of Preventive and Predictive Medicine Fondazione IRCCS Istituto Nazionale Dei Tumori (INT) Milan Italy 3Istituto Nazionale Tumori, Milan, Italy; 68Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy. Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Unit of Medical Genetics, Department of Preventive and Predicted Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy, Julie Lecarpentier, Karoline B. Kuchenbaecker, Daniel Barrowdale, Joe Dennis, Lesley McGuffog, Goska Leslie, Andrew Lee, Ali Amin Al Olama, Jonathan P. Tyrer, Debra Frost, Steve Ellis, Douglas F. Easton, and Antonis C. Antoniou, University of Cambridge; Karoline B. Kuchenbaecker, The Wellcome Trust Sanger Institute, Hinxton; Marc Tischkowitz, Addenbrooke’s Treatment Centre, Addenbrooke’s Hospital, Cambridge; D. Gareth Evans, Manchester University, Central Manchester University Hospitals NHS Foundation... Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan 20133, Italy. Authors' Affiliations: 1Department of Experimental Therapeutics and the Center for RNA Interference and Non-coding RNAs and 2Division of Quantitative Science, The University of Texas M.D. Anderson Cancer Center, Houston, Texas; 3Li Ka Shing Institute of Health Sciences, Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong SAR, China; 4Center for Systems and Computational Biology, Molecular and Cellular Oncogenesis Program, The Wistar Institute, Philadelphia, Pennsylvania; 5Comprehensive Cancer Center, Ohio State University, Columbus, Ohio; 6University of Ljubljana, Biotechnical Faculty Department of Animal Science, Domzale, Slovenia; and 7Unit of Medical Genetics and 8Hormone Research Laboratory, Department of Preventive and Predictive Medicine, 9Immunohematology and Transfusion Medicine Service, Department of Diagnostic Pathology and Laboratories, 10Unit of Genetic Susceptibility to Cancer, Department of Experimental Oncology and Molecular Medicine, Fonda Unit of Medical Genetics, Department of Preventive and Predictive Medicine, National Cancer Institute INT Milan Italy 46Unit of Medical Genetics, Department of Preventive and Predictive Medicine, Fondazione IRCCS Istituto Nazionale Tumori (INT), Milan, Italy. 3Unit of Medical Genetics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Authors' Affiliations: 1Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine; 2The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research; 3Division of Cancer Studies, NIHR Comprehensive Biomedical Research Centre, Guy's & St. Thomas' NHS Foundation Trust in partnership with King's College London, London, United Kingdom; 4Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health and 5Department of Pathology, The University of Melbourne; 6Kathleen Cuningham Consortium for Research into Familial Breast Cancer (kConFab), Research Division, Peter MacCallumCancer Center; 7Cancer Epidemiology Centre, Cancer Council Victoria; 8The Alfred Hospital, Melbourne, Victoria, Australia; Departments of 9Epidemiology and 10Molecular Pathology, The Netherlands Cancer Institute - The Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands; 11Warwick Medical School, Warwick University, Coventry, United Kingdom; 12Departm Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan 20133, Italy. Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. The authors’ affiliations are as follows: the Centre for Cancer Genetic Epidemiology, Departments of Public Health and Primary Care (L.D., S. Carvalho, J.A., K.A.P., Q.W., M.K.B., J.D., B.D., N. Mavaddat, K. Michailidou, A.C.A., P.D.P.P., D.F.E.) and Oncology (C.L., P.A.H., C. Baynes, D.M.C., L.F., V.R., M. Shah, P.D.P.P., A.M.D., D.F.E.), University of Cambridge, Cambridge, the Centre for Genomic and Experimental Medicine, MRC Institute of Genetics and Molecular Medicine (A. Campbell, D.J.P.), and the... Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy Unit of Medical Genetics, Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori (INT), Milan, Italy |
Incoming Links
Total number of triples: 235.